Al Hammadi Holding Co. intrinsic value and dividend analysis using DCF, P/B, PEG and PSG models. Includes dividend yield, payout ratio, and dividend sustainability assessment. Sector: Health Care Equipment & Svc. Listed on Saudi Exchange Tadawul.
Al Hammadi Holding Company provides healthcare services in Saudi Arabia through its Medical Services and Pharmaceuticals Products segments, offering inpatient and outpatient hospital care, radiology, and laboratory services. Formerly named Al Hammadi Company For Development and Investment, it adopted its current name in August 2022. The company was founded in 1985 and is based in Riyadh.
TASIV estimates this company's intrinsic value using a discounted earnings model. As of TASIV's most recent data refresh, the estimated intrinsic value is SAR 15.04 compared to a market price of SAR 24.10 (Trading significantly above DCF model value). This is an analytical estimate, not investment advice.
Revenue increased only slightly over the three-year period, up by about 5%, while net income declined by about 20% and operating cash flow declined by a larger margin of about 39%, both after rising in the second year and then falling sharply in the third. This indicates that profitability and cash generation weakened despite broadly stable revenue. Overall, the company's historical financial performance shows little change in revenue alongside a notable decline in both net income and operating cash flow.
Dividend per share fluctuated over the 5-year recorded period, ranging between SAR 0.67 and SAR 1.45, and ended at SAR 0.67 versus SAR 1.45 at the start. Payments have been made on a Quarterly basis throughout this period. Overall, the company's per-share dividend has varied year to year without a consistent direction. Current dividend yield is approximately 5.19%, with a payout ratio of approximately 82.69%.
TASIV's Competitive Advantage assessment for this company is Moderate (59/100), based on profitability, predictability, financial strength, and growth resilience.
Based on TASIV's discounted earnings model, the estimated intrinsic value of Al Hammadi Holding Co. is approximately SAR 15.04, compared to a current market price of SAR 24.10. This is an analytical estimate based on the company's financial data, not investment advice or a recommendation to buy or sell.
According to TASIV's model, Al Hammadi Holding Co. is currently "Trading significantly above DCF model value".
Al Hammadi Holding Co.'s dividend yield is approximately 5.19%, with a payout ratio of approximately 82.69%, based on TASIV's most recent verified data.
Loading 4007...